Assessment of Ebola virus persistence in vitreous fluid of Ebola virus disease survivors with vitreoretinal disease in Sierra Leone: a cross-sectional study
The Lancet Microbe · 2026-11 · 101547
DOI: 10.1016/j.lanmic.2026.101547 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift The Lancet Microbe, 2026-11. Verfasst von Susanne L Linderman und 52 weiteren Autor:innen. Beteiligte Einrichtung: Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: USAID, Macula Society, National Eye Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
- Stanley M Truhlsen Eye Institute, Department of Ophthalmology, University of Nebraska Medical Center, Omaha, NE, USA.
- Connaught Government Hospital, Ministry of Health, Freetown, Sierra Leone.
- Biosurv International, Salisbury, UK.
- Lowell and Ruth Gess Eye Hospital, Freetown, Sierra Leone.
- Rollins School of Public Health, Emory University School of Medicine, Atlanta, GA, USA.
Förderung
- USAID
- Macula Society
- National Eye Institute
- National Cancer Center
Zitieren
APA
Linderman, S. L., Fashina, T., Harrison-Williams, L. C., Nguyen, N. V., Pratt, C., Kamara, A., Conteh, O., Kanu, T. F., Kamara, S., Saradugu, B., Conteh, I., Campbell, K., Williams, B., Dowrie, H., Sesay, M. N., Mansaray, M., Konneh, A., Rogers, M. D., Mattia, J. G., …, & EVICT-VR Study Investigators (2026). Assessment of Ebola virus persistence in vitreous fluid of Ebola virus disease survivors with vitreoretinal disease in Sierra Leone: a cross-sectional study. The Lancet Microbe, 101547. https://doi.org/10.1016/j.lanmic.2026.101547
Vancouver
Linderman SL, Fashina T, Harrison-Williams LC, Nguyen NV, Pratt C, Kamara A, et al. Assessment of Ebola virus persistence in vitreous fluid of Ebola virus disease survivors with vitreoretinal disease in Sierra Leone: a cross-sectional study. The Lancet Microbe. 2026:101547. doi:10.1016/j.lanmic.2026.101547
BibTeX
@article{Linderman2026,
author = {Linderman, Susanne L and Fashina, Tolulope and Harrison-Williams, Lloyd C and Nguyen, Nam V and Pratt, Catherine and Kamara, Alicious and Conteh, Osman and Kanu, Theophilus F and Kamara, Santigie and Saradugu, Bangi and Conteh, Ibrahim and Campbell, Kenneth and Williams, Benjamin and Dowrie, Hannah and Sesay, Mabel N and Mansaray, Mohamed and Konneh, Agnes and Rogers, Miatta D and Mattia, John G and Vandy, Matthew J and Ward, Laura and Carag, Jessica and Morgan, Jill and Kraft, Colleen S and Brett-Major, David and Hewlett, Angela and Hayek, Brent R and Kuthyar, Sanjana and Song, Helen and Choo, Charlene and Huang, Ye and Balendra, Shiama and Garry, Robert F and Schieffelin, John and Grant, Donald and Zeng, Xiankun and Conrady, Christopher D and Justin, Grant A and Srivastava, Sunil and Smith, Justine R and Drews-Botsch, Carolyn and Doan, Thuy and Shantha, Jessica G and Davis, Carl W and Uyeki, Timothy M and Crozier, Ian and Mwanza, Jean-Claude and Wiley, Michael and Koroma, Zikan and Mustapha, Jalikatu and Ahmed, Rafi and Yeh, Steven and EVICT-VR Study Investigators, EVICT-VR Study Investigators},
title = {Assessment of Ebola virus persistence in vitreous fluid of Ebola virus disease survivors with vitreoretinal disease in Sierra Leone: a cross-sectional study},
journal = {The Lancet Microbe},
year = {2026},
pages = {101547},
doi = {10.1016/j.lanmic.2026.101547}
}
EUVIMED